⌕
Nurix Therapeutics · NRIX · Nasdaq
Tenet 85 · Strong
Compare
$14.67−5.23%At closeTenet 85 · Strong
$14.67−0.81 (−5.23%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
$14.99+0.32 (+2.18%)
After hours: Nov 16, 2026, 4:14 PM ET

Nurix Therapeutics (NRIX) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 212 filers, Jun 30, 2026
# 13F FUNDS
212
13F VALUE
$2.9B
117.5M shares
Not reported in the company's filings for this period.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 4, 2026van Houte HansChief Financial OfficerDisposed · Open-market sale3,300$15.38↗
Nov 4, 2026van Houte HansChief Financial OfficerDisposed · Open-market sale1,469$16.20↗
Nov 3, 2026Ring ChristineChief Legal OfficerDisposed · Open-market sale6,113$25.83↗
Nov 2, 2026Ring ChristineChief Legal OfficerAcquired · Option exercise5,786$8.72↗
Nov 2, 2026Ring ChristineChief Legal OfficerDisposed · Open-market sale9,527$25.74↗
Nov 2, 2026Ring ChristineChief Legal OfficerDisposed · Open-market sale1,075$26.76↗
Nov 2, 2026Ring ChristineChief Legal OfficerDisposed · Option exercise5,786Employee Stock Option (right to buy)—↗
Nov 2, 2026Hansen GwennChief Scientific OfficerAcquired · Option exercise1,452$1.86↗
Nov 2, 2026Hansen GwennChief Scientific OfficerDisposed · Open-market sale1,452$26.80↗
Nov 2, 2026Hansen GwennChief Scientific OfficerDisposed · Option exercise1,452Employee Stock Option (right to buy)—↗
Oct 30, 2026van Houte HansChief Financial OfficerAcquired · Option exercise3,750—↗
Oct 30, 2026van Houte HansChief Financial OfficerAcquired · Option exercise2,859—↗
Oct 30, 2026van Houte HansChief Financial OfficerAcquired · Option exercise3,573—↗
Oct 30, 2026van Houte HansChief Financial OfficerDisposed · Open-market sale2,834$26.28↗
Oct 30, 2026van Houte HansChief Financial OfficerDisposed · Option exercise3,750Restricted Stock Units—↗
Oct 30, 2026van Houte HansChief Financial OfficerDisposed · Option exercise2,859Restricted Stock Units—↗
Oct 30, 2026van Houte HansChief Financial OfficerDisposed · Option exercise3,573Restricted Stock Units—↗
Oct 30, 2026Ring ChristineChief Legal OfficerAcquired · Option exercise3,750—↗
Oct 30, 2026Ring ChristineChief Legal OfficerAcquired · Option exercise2,859—↗
Oct 30, 2026Ring ChristineChief Legal OfficerAcquired · Option exercise3,573—↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold Nurix Therapeutics?

Nurix Therapeutics was held by 212 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.